RBNZ Chair Says Orr ‘Lost His Cool' With Treasury Officials
Quigley and Orr met with Treasury officials on Feb. 20 to discuss the central bank's five-year funding agreement with the government, Treasury said in response to questions from Bloomberg News and other media.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
31 minutes ago
- Bloomberg
CuspAI in Talks to Raise $100 Million to Discover New Materials
British startup CuspAI is in talks to raise more than $100 million in funding to support its goal of using artificial intelligence models to discover new materials, according to people familiar with the matter. Founded in 2024, CuspAI uses generative AI and molecular simulation to build a platform that it likens to a highly specialized search engine. Users can describe properties they'd like a new material to have and the service responds with a chemical makeup.
Fox News
2 hours ago
- Fox News
FBI office in New Zealand will defend against Chinese influence, Patel says
FBI Director Kash Patel visited New Zealand over the weekend to launch the bureau's new office there, saying the country was a crucial partner for fighting Chinese influence in the Indo-Pacific region. Patel said the international field office, known as a legal attaché office, was the first such office to open in decades. The FBI has more than 60 offices across the globe designed to focus on international threats and intelligence building. Fresh off a meeting with Five Eyes partners in the region, Patel laid out the FBI New Zealand office's priorities. "Some of the most important global issues of our times are the ones that New Zealand and America work on together, countering the CCP (Chinese influence) in the INDOPACOM theatre, countering the narcotics trade, working against cyber intrusions and ransomware operations, and most importantly, protecting our respective citizenry here in New Zealand, at home in America and across the world," Patel said in a statement. The Five Eyes alliance is a decades-old global group of five countries that share intelligence with each other for national security purposes. In addition to the United States and New Zealand, it includes the United Kingdom, Canada and Australia. New Zealand has faced pressure to align more closely with the United States on China while also balancing its own relationship with Beijing, according to The Associated Press. China took issue with the FBI's announcement in remarks on Friday, saying it did not support the two countries teaming up against a third country. "Seeking so-called absolute security through forming small groupings under the banner of countering China does not help keep the Asia Pacific and the world at large peaceful and stable," Foreign Ministry spokesperson Guo Jiakun said. Judith Collins, New Zealand's communications security bureau minister, said the FBI's presence would help with crime. "I think it's about the transnational crime that we see, the increasing influence of major drug traffickers across the Pacific, but also interference in countries; systems, particularly when I look at some of the gun-running sort of type behavior that we know goes on [in] the Pacific," Collins said, adding that "it's just the reality is we have similar issues that we have to deal with. And it's great to have the FBI upgrading its presence." From racing against China to achieve technological advances to prosecuting possible instances of espionage and raising worries about China's ownership of a small fraction of U.S. farmland, the U.S. government has signaled a heightened concern with Chinese influence on numerous fronts. China has also been a driving force behind the opioid crisis in the United States. The Drug Enforcement Administration found in 2020 that the illicit drug flow into the country originated primarily with China.
Yahoo
4 hours ago
- Yahoo
Afaxys Secures $8 Million to Advance Mission and Accelerate Growth Strategy
CHARLESTON, S.C., Aug. 4, 2025 /PRNewswire/ -- Afaxys, Inc., a socially conscious healthcare company focused on serving the reproductive health needs of public health professionals and their patients, announces it has secured $8 million in new funding from two large foundations to support its mission and propel its growth strategy. The capital includes a $3 million program-related investment (PRI) from the David and Lucile Packard Foundation and a $5 million grant from an anonymous foundation. This marks the third investment from the Packard Foundation since Afaxys was founded in 2008, underscoring the long-standing partnership and confidence in Afaxys' impact-driven model. "Through our mission-based investments, Afaxys has grown into a durable and financially sustainable force in the market that will continue to actively ensure and continually expand reproductive health access for all patients, especially those served by public health providers," said Susan Phinney-Silver, Mission Investing Director at the David and Lucile Packard Foundation. The new funding serves as a catalyst for growth as Afaxys continues its mission of providing millions of women in the United States access to affordable contraception. Afaxys is the only organization of its kind with an established, nationwide distribution infrastructure serving public health clinics. Afaxys plays a critical role in ensuring reliable supply chains for clinics that serve Medicaid and Title X patients. The funding will be used to complete the development of a novel contraceptive product, specifically designed to address the needs of marginalized communities and the more than 19 million women living in contraceptive deserts. "Access to quality reproductive healthcare has never been more critical. We are excited to partner with these esteemed foundations to further the Afaxys mission and ensure that access to reproductive healthcare is a right, not a privilege," said Ronda Dean, CEO of Afaxys, Inc. About Afaxys Afaxys, a Public Benefit Corporation, uniquely partners with public health and private industry to ensure healthcare professionals have stable pricing and reliable access to the products and services they need to care for their patients. The Afaxys enterprise comprises a family of companies that operate under three wholly owned subsidiaries: Afaxys Pharma, LLC, Afaxys Drug Development, LLC and Afaxys Group Services, LLC (AGS). Afaxys Pharma provides a broad portfolio of branded and generic contraceptives to the public healthcare market. Afaxys Drug Development provides development and regulatory services of pharmaceutical products with a focus on rapid and efficient launch readiness to promote Afaxys' strategic goal of cost-conscious product commercialization. AGS is a strategic sourcing operation that negotiates favorable pricing across a broad base of products and services through its Group Purchasing Organization. For more information, visit Forward-Looking Statements The statements in this press release that are not historical facts constitute "forward-looking statements" as defined by Federal Securities laws. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, but are not limited to, risks related to the inability to implement strategic initiatives, and the dependence on key personnel. Forward-looking statements speak only as of the date they are made. Afaxys, Inc. will not update forward-looking statements to reflect factual assumptions, circumstances or events that have changed after a forward-looking statement was made. Afaxys Media ContactGreen Room Communicationsgr_afaxys@ View original content to download multimedia: SOURCE Afaxys, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
